Dianthus Therapeutics (DNTH) Receivables - Net (2022 - 2025)
Historic Receivables - Net for Dianthus Therapeutics (DNTH) over the last 4 years, with Q3 2025 value amounting to $5.0 million.
- Dianthus Therapeutics' Receivables - Net rose 25971.22% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year increase of 25971.22%. This contributed to the annual value of $294000.0 for FY2023, which is 9374.47% down from last year.
- According to the latest figures from Q3 2025, Dianthus Therapeutics' Receivables - Net is $5.0 million, which was up 25971.22% from $39000.0 recorded in Q2 2025.
- Dianthus Therapeutics' Receivables - Net's 5-year high stood at $5.0 million during Q3 2025, with a 5-year trough of $39000.0 in Q2 2025.
- For the 4-year period, Dianthus Therapeutics' Receivables - Net averaged around $1.5 million, with its median value being $840000.0 (2024).
- Its Receivables - Net has fluctuated over the past 5 years, first soared by 49913.79% in 2024, then plummeted by 9535.71% in 2025.
- Quarter analysis of 4 years shows Dianthus Therapeutics' Receivables - Net stood at $4.7 million in 2022, then crashed by 93.74% to $294000.0 in 2023, then skyrocketed by 372.79% to $1.4 million in 2024, then surged by 259.71% to $5.0 million in 2025.
- Its last three reported values are $5.0 million in Q3 2025, $39000.0 for Q2 2025, and $1.0 million during Q1 2025.